BioCentury
ARTICLE | Company News

Axis Biochemicals, Shield Diagnostics Ltd. deal

January 25, 1999 8:00 AM UTC

The diagnostic companies agreed in principle to merge, with Axis shareholders receiving one SDG share for each Axis share held. SDG shareholders would own 62 percent and Axis shareholders 38 percent o...